在非小细胞肺癌中,RB1-I680T突变通过消除E2F1转录的抑制来增强瘤生长和化疗敏感性

相关实验视频

Updated: Feb 2, 2026

05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

415

Yilin Zhu¹, Fengyuan Gao¹, Yu Liu^1,2

¹Department of Thoracic Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Cell communication and signaling : CCS

|January 31, 2026

概括

在非小细胞肺癌 (NSCLC) 中的一种罕见的RB1-I680T突变促进瘤生长并增强化疗反应. 这种RB1突变破坏了瘤抑制,为个性化NSCLC治疗策略提供了潜在的生物标志物.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

视网母细胞瘤转录核抑制剂1 (RB1) 是一个关键的瘤抑制基因.
通过失去瘤抑制功能,RB1突变往往导致癌症.
罕见的RB1变体在非小细胞肺癌 (NSCLC) 中的作用尚不清楚.

研究的目的:

研究NSCLC中新型RB1误解突变 (I680T) 的功能和机制影响.
为了确定RB1-I680T是否影响瘤生长,增殖和化学敏感性.
阐明RB1-I680T突变影响的分子机制.

主要方法:

使用CRISPR-Cas9和lentivirus生成的NSCLC细胞模型,具有RB1淘汰和RB1-I680T或野生型RB1 (RB1-WT) 表达.
通过体外和体外实验评估生物表型.
通过共免疫沉,免疫光,光酶试验,西部污染和蛋白质模拟来探索分子机制.

主要成果:

与RB1-WT相比,RB1-I680T突变加速了瘤的生长.
RB1-I680T强化化疗诱导的瘤回归.
这种突变通过削弱RB1-E2F1相互作用来削弱RB1对E2F1转录活性的抑制,这取决于RB1口袋B域的灵活性.

结论:

在NSCLC中,RB1-I680T突变导致功能丧失,促进增殖并赋予化学敏感性.
在NSCLC患者中,RB1-I680T可以作为化疗反应的预测生物标志物.
根据RB1-I680T状态对患者进行分层,可以实现个性化治疗,特别是对于E2F1-dysregulated瘤.

关键词:

化学疗法敏感性化学疗法敏感性 E2F1 E2F1 E2F1 E2F1 E2F1 E2F1 E2F1 E2F1 E2F1 在NSCLCLC中,我们可以看到.核武器的扩散在 RB1-I680T 中使用.

相关概念视频

02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.9K

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Mutations

Cancer Stem Cells and Tumor Maintenance

6.0K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

6.0K

02:58

Cell Potential and Free Energy

46.5K

Thermodynamics of a Redox Reaction
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...

46.5K

00:36

Viral Mutations

39.9K

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

39.9K

01:10

Transcription

156.3K

Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...